Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts, Published online: 14 November 2018; doi:10.1038/s41416-018-0312-6
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenograftshttps://ift.tt/2PTWgSK
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.